Knee Regeneration Glendale: help for a sore knee, not a promise to grow it back

What to do before another active day

A knee often gets sore as its smooth bone covering wears down. Doctors call that covering cartilage. Arthritis is one common reason for the wear. An injury or swelling can cause trouble too. Your doctor may suggest exercise suited to how strong and steady you feel. Using a cane or brace may ease the load. Medicines such as ibuprofen or naproxen may calm swelling and soreness. They aren't safe with every health problem or medicine, so ask first.

If an earlier exercise plan didn't help, tell the doctor what hurt. The exercises may need a slower start or a change. You aren't required to push through sharp soreness.

Ask yourself whether moving feels easier afterward.

When to arrange a knee visit

Arrange an exam if soreness limits sleep, walking, or errands. Ongoing swelling, locking, or a knee that buckles also deserves attention. Take physical therapy notes, your medicine list, and any X-ray report. Record when the ache first showed up and which movements bring it on.

At QC Kinetix, regenerative care uses substances already found in the body. One offering is platelet-rich plasma (PRP). After drawing your blood, a provider uses a spinning machine to separate the platelets from the rest. The platelet-rich liquid is then placed into the sore knee at the clinic. The medical team reviews your health and examines the joint first. They'll explain whether this non-surgical choice may suit your soreness. A certain response can't be promised.

You'll leave a useful visit knowing the next step.

What needs care sooner

A fever and a hot, badly swollen knee need medical care that day. After an injury, get prompt help when the leg won't bear weight. A bent knee that truly won't move also needs quick attention. Chills with fast-growing soreness can't wait either.

Worsening soreness at night needs a timely exam. Numbness, weakness, or several swollen joints need one too. Long morning stiffness in those joints can point to another cause. A routine treatment visit isn't the right first stop for these problems.

When you're unsure, a doctor can judge how soon you need care.

Sources

1. A cross-sectional study contacted 273 of 317 US centres offering direct-to-consumer stem-cell therapy, posing as a 57-year-old man with knee osteoarthritis. The mean advertised price of a unilateral same-day stem-cell knee injection was $5,156 (SD $2,446), and centres claimed a mean clinical efficacy of 82% (SD 9.6%) - a figure with no support in the published evidence. The gap between the quoted number and the trial data is the single most useful thing a patient can be told before a consultation.

   Piuzzi NS, et al. — The Stem-Cell Market for the Treatment of Knee Osteoarthritis: A Patient Perspective.. The journal of knee surgery, 2018. DOI: 10.1055/s-0037-1604443.

2. Medicare's National Coverage Determination covers autologous platelet-rich plasma ONLY for chronic non-healing diabetic, pressure or venous WOUNDS, and only under Coverage with Evidence Development inside an approved clinical research study. There is no Medicare coverage pathway for PRP as a treatment for osteoarthritis or any other joint indication, which is why these injections are quoted as cash prices.

   Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2012.

3. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

4. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

5. The 2019 ACR/Arthritis Foundation guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-efficacy and self-management programs, tai chi, cane use, tibiofemoral bracing, topical NSAIDs, oral NSAIDs and intra-articular glucocorticoid injection in knee OA. Notably it does NOT strongly recommend any biologic injectable.

   Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis & rheumatology (Hoboken, N.J.), 2020. DOI: 10.1002/art.41142.